ReviewFrontiers in neurology
Brain alteration of PCOS: neuroimaging and function.
Review in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Integrative Multi-omics Analysis for Prioritization of Candidate Genes in Polycystic Ovary Syndrome.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Polycystic ovary syndrome (PCOS), a common endocrine disorder affecting women, continues to be inadequately understood in terms of its pathogenesis. However, it is strongly associated with structural and functional abnormalities in the brain. This review examines neuroimaging alterations and cerebral functional changes observed in patients with PCOS, investigating their relationships with endocrine-metabolic profiles, behavioral patterns, cognitive performance, and emotional regulation. Neuroimaging studies have identified several key findings, including the enlargement of the pituitary gland (encompassing both the anterior and posterior regions, but excluding the infundibular stalk), a reduction in gray matter volume, and damage to the corpus callosum within the white matter. In patients with PCOS, structural alterations and changes in activity states within specific brain regions are associated with abnormal glucose metabolism, disordered eating behaviors, and cognitive and emotional changes. Notably, elevated μ-opioid receptor binding capacity in emotion-related brain regions and altered activity in the right orbitofrontal cortex under sympathetic activation has been observed. Collectively, these alterations point to a dysfunction of the limbic system circuitry, which may underlie the prevalent affective and cognitive symptoms in PCOS. Such neural imaging changes provide critical insights into PCOS pathophysiology and therapeutic development, though further investigations are warranted to address unresolved mechanistic questions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.